title: Response to comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.
authors.affiliation: Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Caroline K
authors.initials: CK
authors.lastname: Kramer
authors.affiliation: Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
authors.forename: Ravi
authors.initials: R
authors.lastname: Retnakaran
authors.affiliation: Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada zinman@lunenfeld.ca.
authors.forename: Bernard
authors.initials: B
authors.lastname: Zinman
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D002239:Carbohydrate Metabolism, Inborn Errors / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D005260:Female; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000008:administration & dosage*; D005991:Glycerol Kinase / Q000172:deficiency*; D006801:Humans; D008297:Male
chemical_list: D001786:Blood Glucose; D005934:Glucagon; D005991:Glycerol Kinase; D005947:Glucose